Abstract: New use of 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1H-indole-5-carbonitrile as a free base or a pharmaceutically acceptable salt thereof, in a method of prevention and/or treatment of bone-related disorders, osteoporosis, increasing bone formation or increasing bone mineral density.
Type:
Application
Filed:
January 31, 2007
Publication date:
September 3, 2009
Applicant:
ASTRAZENECA AB GLOBAL INTELLECTUAL PROPERTY